Cargando…
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses
Increased sensitivity of cancer cells to viruses is a prerequisite for the success of oncolytic virotherapy. One of the major causes of such a phenotype is the disruption of innate antiviral defenses associated with dysfunction of type 1 interferons (IFNs) that permits unlimited replication of virus...
Autores principales: | Matveeva, Olga V., Chumakov, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906582/ https://www.ncbi.nlm.nih.gov/pubmed/30209859 http://dx.doi.org/10.1002/rmv.2008 |
Ejemplares similares
-
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
por: Zainutdinov, Sergei S, et al.
Publicado: (2019) -
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)
por: Ilyinskaya, Galina V., et al.
Publicado: (2018) -
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
por: Matveeva, Olga V., et al.
Publicado: (2020) -
Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
por: Achard, Carole, et al.
Publicado: (2015) -
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
por: Hamad, Azzam, et al.
Publicado: (2023)